Quellen
Zimerman et al.. Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab. NEJM Evid. 2025 Jan;4(1):EVIDoa2400112. doi: 10.1056/EVIDoa2400112. Epub 2024 Dec 24. PMID: 39718423.
Edelmann et al.. Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial. Nat Med. 2025 Jan;31(1):306-314. doi: 10.1038/s41591-024-03342-7. Epub 2025 Jan 2. PMID: 39747684; PMCID: PMC11750725.